Gregor Robertson, federal Minister of Housing and Infrastructure and Minister responsible for Pacific Economic Development Canada (PacifiCan) –

“British Columbians have the talent and ingenuity to lead the future of health innovation. These investments will help B.C. businesses leverage the power of AI and other technologies to improve patient care, expand access in rural and remote communities, and speed up breakthroughs in diagnostics and drug discovery. PacifiCan is committed to ensuring businesses have the support they need to grow and contribute to one strong Canadian economy.”

Josie Osborne, B.C. Minister of Health –

“People in B.C. deserve the best care possible and these made-in-B.C. projects will deliver real results. With breakthroughs like AI-powered drug discovery and faster digital diagnostics, it will be amazing to see these B.C.-made innovations go from the research lab directly to front-line health-care teams and patients to help improve health outcomes.” 

Mahdi Mobini, managing director, Daric Clouding Solutions –

“Thanks to support from Innovate BC and Provincial Health Services Authority, British Columbians benefit from a robust platform that brings advanced digital pathology services to patients across the province. With cutting-edge AI integrations underway to boost laboratory efficiency, B.C.’s health-care ecosystem is uniquely positioned to export the IMI-supported innovative digital pathology solutions globally.”

Hamid Farshchi, CEO and co-founder, D2Type Health Inc. –

“We are excited to work with the Jim Pattison Centre for Health Systems Learning + Innovation and Interior Health to help expand more continuous, personalized diabetes support across community-care settings in British Columbia. This initiative represents an important step toward enabling more proactive, AI-enabled between-visit care for people living with diabetes and cardiometabolic conditions.”

Dee Taylor, executive director, JP Centre for Health Systems Learning + Innovation –

“Innovate BC’s support strengthens our ability to test an AI-enabled model that provides meaningful between-visit support while fitting naturally into existing clinical workflows. Together with D2Type and with Interior Health observing the implementation, we’re generating the real-world evidence needed to guide responsible scale up across the Interior.”

Max Jajszczok, executive director, community hospitals and rural remote services, Island Health –

“This funding allows Island Health to explore the exciting potential of drone delivery for critical medical supplies, improving timely access for rural and remote communities and during emergencies. We are grateful to work with Quaternion Aerospace and the University of Victoria Centre for Aerospace Research, as their expertise and innovation is critical to exploring and realizing this opportunity.”

Winnie Liang, co-founder and CEO, Ma Robot AI –

“Ma Robot AI is the self-driving company for robots, starting with health care. Supported by Royal Columbian Hospital Foundation and Innovate BC, we are pioneering advanced navigation AI for autonomous hospital transport. By safely moving supplies and lab samples through high-traffic environments, we aim to improve operational efficiency, reduce staff workload and enhance patient care.”

Brian Simmers, president, Providence Health Care Ventures –

“In health care, innovation only matters when it works in the real world. Creating space within care settings to test and refine new technologies helps build trust with the clinicians and teams who use them every day. That kind of hands-on validation reduces risk, speeds up adoption and helps promising ideas turn into solutions that truly strengthen care delivery, support the workforce and improve system performance.”

Amlan Chakladar, solutions architect, Quartech Systems –

“As a B.C.-based company, Quartech is proud to contribute to health innovation that has the potential to benefit our neighbours, families and communities across the province. Through the health testbed, we are showcasing how cloud and AI can meaningfully improve quality and diagnostic accuracy in pathology workflows, while the concordance testing framework established for immunohistochemistry creates a strong foundation for future innovation.”

Afzal Suleman, president and CEO, Quaternion Aerospace –

“Quaternion Aerospace is thrilled to help showcase advanced autonomous aircraft solutions within a real-world health-care testbed environment. Our longstanding collaboration with the University of Victoria Centre for Aerospace Research combines proven flight operations with the innovation needed to advance these technologies through the Integrated Marketplace initiative.”

Kenneth To, CEO, ViewsML –

“We’re appreciative of the Province’s support as we advance faster, more consistent and scalable biomarker detection. As Providence Health Care Ventures has one of the largest biobanks, it is nearly impossible to characterize biomarker expression manually due to wet lab and tissue constraints. Our AI-powered virtual staining technology predicts biomarker expression from a single digital H&E image in minutes, thereby generating commercial-ready datasets without consuming precious tissue samples.”

Daniel Wattier, CEO, 3C Therapeutics Inc. –

“AI is allowing us to search for promising new cancer medicines faster and more efficiently than traditional drug discovery methods. By combining Variational AI’s platform with 3C’s degrader-antibody conjugate technology, this collaboration has the potential to accelerate the development of more targeted therapies, while strengthening British Columbia’s position in AI-enabled biotech innovation.”

Ashish Anand, CEO, Workforce Wellness –

“Currently, 1.2 million patients in B.C. are on a wait list for an initial consultation with a specialist. That’s one out of every five British Columbians. Workforce Wellness is tackling this acute challenge with Agentic AI to streamline health-care operations and dramatically reduce these wait times. By automating administrative tasks, we free up clinicians to increase throughput and focus on delivering care to patients.”

 Jeff Norris, president and CEO, Royal Columbian Hospital Foundation –

“Caring for those who care for others is a priority for our foundation. We know the demands on physicians, nurses and care teams continue to grow, often in ways that are not always visible. Innovate BC’s support allows us to explore innovative solutions to help ease time pressures on clinical teams and support patient care.”

Additional Integrated Marketplace Health Testbed projects

• Vancouver-based D2Type and Jim Pattison Centre for Health Systems Learning + Innovation will receive $850,000 to expand the use of an AI-enabled platform that supports people living with pre-diabetes and Type 2 diabetes. The project will focus on preparing the technology for broader use across community-care settings throughout the Interior.
• Richmond-based Ma Robot AI and Royal Columbian Hospital Foundation received $350,000 to pioneer the advanced navigation AI required to make robotic porters a reality in high-traffic hospitals.
• Victoria-based Quartech and Provincial Laboratory Medicine Services received $710,000 to test AI technology that helps automate the quality checks in paediatric pathology, improving accuracy and efficiency in lab processes.
• Island Health and Sidney-based Quaternion Aerospace received $425,000 to test the use of autonomous drones to deliver medical supplies, including during emergencies, helping improve access to health care in rural and remote communities.
• Vancouver-based SapienSecure and Island Health received $200,000 to test AI tools that identify and correct coding and billing errors in radiology, helping streamline administrative processes.
• B.C.-based Workforce Wellness and Royal Columbian Hospital Foundation will receive $557,000 to test AI tools designed to reduce time spent on administrative tasks, allowing nurses to focus more on patient care.
• Vancouver-based ViewsML and Providence Health Care Venture will receive over $172,000 to test AI powered virtual biomarkers that support pathology analysis.